Multicentric Clinical Data Collection: A Game-Changer for Rare Neurological Diseases

被引:0
|
作者
Bruffaerts, Rose [1 ,2 ]
Crosiers, David [2 ,3 ]
机构
[1] Univ Antwerp, Dept Biomed Sci, Computat Neurol, Expt Neurobiol Unit, Antwerp, Belgium
[2] Antwerp Univ Hosp, Dept Neurol, Antwerp, Belgium
[3] Univ Antwerp, Translat Neurosci, Fac Med & Hlth Sci, Antwerp, Belgium
关键词
Alzheimer's disease; frontotemporal dementia; pharmacology; psychiatry; psychopharmacology; therapeutics; FRONTOTEMPORAL DEMENTIA;
D O I
10.3233/JAD-230788
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although neuropsychiatric symptoms are a hallmark of the behavioral variant of frontotemporal degeneration (FTD), there is limited evidence on the optimal therapeutic management of these symptoms. In this issue, Katisko et al. report real-world multicentric data on the use of psychopharmacological medication in newly diagnosed patients with FTD. Such reports contribute to knowledge sharing between clinicians caring for patients with FTD. Here, we outline howimproved collection of clinical data can assure more robust evidence for future therapies in FTD and other rare neurological diseases.
引用
收藏
页码:687 / 689
页数:3
相关论文
共 45 条
  • [1] HOMOZYGOSITY MAPPING: A GAME-CHANGER FOR AUTOSOMAL RECESSIVE DISEASES
    Alkuraya, Fowzan S.
    NATURE REVIEWS GENETICS, 2022, 23 (01) : 2 - 3
  • [2] Homozygosity mapping: a game-changer for autosomal recessive diseases
    Alkuraya, Fowzan S.
    NATURE REVIEWS GENETICS, 2021,
  • [3] Homozygosity mapping: a game-changer for autosomal recessive diseases
    Fowzan S. Alkuraya
    Nature Reviews Genetics, 2022, 23 (1) : 2 - 3
  • [4] Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
    Zemla-Pacud, Zaneta
    Lenarczyk, Gabriela
    IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2023, 54 (05) : 732 - 763
  • [5] Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
    Żaneta Zemła-Pacud
    Gabriela Lenarczyk
    IIC - International Review of Intellectual Property and Competition Law, 2023, 54 : 732 - 763
  • [6] Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
    Wei-Chen Huang
    Yuan-Chi Li
    Pin-Xuan Chen
    Kevin Sheng-Kai Ma
    Li-Tzu Wang
    Stem Cell Research & Therapy, 16 (1)
  • [7] Genetic data not yet a "game-changer" for predicting individualised hepatocellular carcinoma risk
    Innes, Hamish
    JOURNAL OF HEPATOLOGY, 2023, 78 (03) : 460 - 462
  • [8] Cardiac arrest centre accreditation in Germany: A game-changer for favourable neurological outcomes after cardiac arrest
    Goto, Yoshikazu
    RESUSCITATION, 2024, 194
  • [9] Colonic probiotic insufflation: clinical proposal for an economical game-changer for restoration of the gut microbiome in colorectal cancer and beyond
    Varghese, Ryan
    Pal, Kavita
    Gota, Vikram
    Islam, Md. Fokhrul
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (05) : 2515 - 2519
  • [10] Natural products act as game-changer potentially in treatment and management of sepsis-mediated inflammation: A clinical perspective
    Zhang, Chi
    Singla, Rajeev K.
    Tang, Min
    Shen, Bairong
    PHYTOMEDICINE, 2024, 130